2026 NPPES data Dermatology Physician NPI 1689153454 PA-C
Verify on CMS →

Maeve Tobin, PA-C

Dermatology Physician in Pawtucket, Rhode Island.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 15,011 in Dermatology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
588
Medicare Part D claims · 293 beneficiaries · Dermatology Physician avg: 799
Generic prescribing
92%
generic claims · 8% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$4.5K
129 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

Maeve Tobin, PA-C filed 588 Medicare Part D claims in 2024 as a Dermatology Physician in Pawtucket, Rhode Island, prescribing 92% generic.

588
Part D claims, 2024
92%
generic prescribing
Likely
board-certified (heuristic)
≥65th
pct by Part D claim volume (lower-bound band)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Maeve Tobin, PA-C

Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1689153454), first enumerated 08/12/2018.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 588 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    Board certification signal

    Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.

    Source: NUCC taxonomy + CMS participation heuristic

  • Reported

    Hospital affiliations

    1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.

    Source: CMS Care Compare

  • Reported

    Industry payment transparency

    $4.5K in reported industry payments (129 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.

    Source: CMS Open Payments

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

CMS NPPES provider registry desk

NPI 1689153454 · Dermatology Physician

NPI-10 · ENUM-RECENT · TAX-MID · RX-LIGHT · BOOK-THIN · PHOTO-ENUM

  • NPI-10 1689153454
  • ENUM-RECENT 2018
  • TAX-MID 15K Dermatology Physician
  • RX-LIGHT 588
  • BOOK-THIN 66 in Rhode Island
  • PHOTO-ENUM Eric Merrill, MD · 2018

Maeve Tobin, PA-C's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2024, across all CMS prescribers nationally

588 ≥ 65th percentile 65% of 1,416,883 prescribers are in lower value bands

0–200: 679,947 prescribers (48%). Below this entry. 200–400: 188,835 prescribers (13%). Below this entry. 400–600: 95,866 prescribers (7%). This entry sits in this band. 600–800: 60,107 prescribers (4%). Above this entry. 800–1,000: 43,043 prescribers (3%). Above this entry. 1,000–1,200: 33,612 prescribers (2%). Above this entry. 1,200–1,400: 27,889 prescribers (2%). Above this entry. 1,400–1,600: 23,183 prescribers (2%). Above this entry. 1,600–1,800: 19,917 prescribers (1%). Above this entry. 1,800–2,000: 17,585 prescribers (1%). Above this entry. 2K+: 226,899 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.

Source CMS Medicare Part D Prescriber Public Use File · 2024

Board certification likely (heuristic, not verified)

Maeve Tobin, PA-C practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Maeve Tobin, PA-C?

Quality data not reported

NPI registry status

Active

Issued 08/12/2018

NPI 1689153454

Primary specialty

Dermatology Physician

Mid-sized

15,011 US NPIs in this specialty

Medicare Part D claims

588 26% vs specialty avg

2024 prescription claims

Specialty avg: 799

Specialty distribution in Rhode Island

How Dermatology Physician compares to other specialties among Rhode Island providers

Rhode Island providers
Clinical Social Worker8.9%Mental Health Counselor5.3%Physical Therapist4.7%Student in an Organized Heal…4.6%Internal Medicine Physician4.2%Pharmacist4.1%Dermatology Physician0.3%
Largest specialties in Rhode Island (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Dermatology Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

333 SCHOOL ST STE 112A
Pawtucket, RI 02860

Provider Details

NPI 1689153454
Specialty Dermatology Physician
Credentials PA-C
Gender Female
NPI Issued 08/12/2018

Hospital and facility affiliations

Facilities where Maeve Tobin, PA-C bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Northeast Dermatology Associates PC
North Andover, MA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Maeve Tobin, PA-C. Source: openpaymentsdata.cms.gov.

Total received

$4.5K

Largest payer

E.R. Squibb & Sons, L.L.C.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Generic-heavy

Maeve Tobin, PA-C - brand share 8.0%
Dermatology Physician average

8% brand-name claims vs 92% generic, on 588 2024 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

588
Total Claims
$214K
Total Drug Cost
293
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
695.267
Total Day Supply
18,829
Brand vs Generic
8% brand / 92% generic
Brand Drug Cost
$198K
Generic Drug Cost
$16K
Antibiotic Claims
52

Patient Demographics

Average Patient Age
71.2 years
Avg HCC Risk Score
1.10
Gender Split
68% female / 32% male
Age Distribution
<65: 45, 65-74: 140, 75-84: 85, 85+: 23

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

What Maeve Tobin, PA-C prescribes most

Top Medicare Part D drugs by claim count, 2024

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2024
Drug Claims
Triamcinolone Acetonide
106
Doxycycline Hyclate
53
Clobetasol Propionate
50
Betamethasone Diprop Augmented
Betamethasone/Propylene Glyc
46
Ketoconazole
44
Doxycycline Monohydrate
35
Clindamycin Phosphate
33
Hydrocortisone
31
Metronidazole
27
Fluorouracil
22

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Dermatology Physician Overview

How Maeve Tobin, PA-C fits within the Dermatology Physician landscape nationally.

15,011
Dermatology Physician Providers in US
53
States with Dermatology Physician
799
Avg Claims per Provider

Maeve Tobin, PA-C's 588 claims are below the specialty average of 799.

Nationwide Dermatology Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Tobin, both outside Rhode Island so the neighborhoods are not geographic containment.

Same NPPES enumeration year (2018)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Dermatology Physician Providers in Rhode Island

Other clinicians with the same primary specialty enrolled in Rhode Island, drawn from the same CMS NPPES roster as Tobin.

One of 66 Dermatology Physician providers enrolled in Rhode Island, 5 are shown here.

Compare Dermatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is Maeve Tobin, PA-C's specialty?
Maeve Tobin, PA-C specializes in Dermatology Physician and practices in Pawtucket, Rhode Island. Credentials: PA-C.
How much does Maeve Tobin, PA-C prescribe under Medicare Part D?
In 2024, Maeve Tobin, PA-C wrote 588 Medicare Part D claims totaling $214K in drug costs for 293 beneficiaries.
Where is Maeve Tobin, PA-C located?
Maeve Tobin, PA-C is located at 333 SCHOOL ST STE 112A, Pawtucket, RI, 02860. Phone: (401) 728-6990.
What is Maeve Tobin, PA-C's NPI number?
Maeve Tobin, PA-C's National Provider Identifier (NPI) is 1689153454, issued on 08/12/2018.
Does Maeve Tobin, PA-C prescribe more brand-name or generic drugs?
Maeve Tobin, PA-C's prescribing is 8% brand-name and 92% generic drugs by claim count, with $198K in brand drug costs.
How many Dermatology Physician providers are there in the US?
There are 15,011 Dermatology Physician providers across 53 states in the US. The average Dermatology Physician provider writes 799 Medicare Part D claims per year.
What drugs does Maeve Tobin, PA-C prescribe most often?
Based on 2024 Medicare Part D data, Maeve Tobin, PA-C's most frequently prescribed drugs include Triamcinolone Acetonide, Doxycycline Hyclate, Clobetasol Propionate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Maeve Tobin, PA-C accept Medicare?
Maeve Tobin, PA-C appears in CMS Medicare data with 588 Part D claims and 293 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Maeve Tobin, PA-C's credentials?
Maeve Tobin, PA-C's NPI is 1689153454 with credentials PA-C. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.